Hematology

Medicine & Life Sciences

1. Lymphoma, Large B-Cell, Diffuse 100%
2. Lymphoma 68%
3. Acute Myeloid Leukemia 62%
4. Rituximab 61%
5. B-Cell Lymphoma 55%
6. Non-Hodgkin's Lymphoma 49%
7. Drug Therapy 40%
8. Leukemia 28%
9. Myelodysplastic Syndromes 27%
10. Survival 26%
11. Human Herpesvirus 4 24%
12. Mantle-Cell Lymphoma 22%
13. Therapeutics 22%
14. Hodgkin Disease 21%
15. Granulocyte Colony-Stimulating Factor 21%
16. Neoplasms 21%
17. Japan 19%
18. Bone Marrow 19%
19. Febrile Neutropenia 18%
20. Serum 17%
21. Vincristine 17%
22. Progression-Free Survival 15%
23. DNA 15%
24. B-Lymphocytes 15%
25. Doxorubicin 15%
26. Methotrexate 14%
27. Induction Chemotherapy 14%
28. Cyclophosphamide 14%
29. Etoposide 14%
30. 9,10-anthraquinone 13%
31. Dexamethasone 13%
32. Hematologic Neoplasms 13%
33. Prednisolone 12%
34. Leukemia, Myelogenous, Chronic, BCR-ABL Positive 12%
35. Elderly 12%
36. Peripheral T-Cell Lymphoma 12%
37. Safety 12%
38. Micafungin 12%
39. Central Nervous System 12%
40. Osteoclasts 11%
41. T-Cell Lymphoma 11%
42. Multi-centric Castleman's Disease 10%
43. Genes 10%
44. Adult T Cell Leukemia Lymphoma 10%
45. Ifosfamide 10%
46. Natural Killer T-Cells 10%
47. Graft vs Host Disease 10%
48. Mutation 10%
49. Immunoglobulin Light Chains 9%
50. Blood Cells 9%
51. Disease-Free Survival 9%
52. Gene Fusion 9%
53. Anaplastic Large-Cell Lymphoma 9%
54. Confidence Intervals 9%
55. Marginal Zone B-Cell Lymphoma 9%
56. Bone Marrow Transplantation 9%
57. Cell-Free Nucleic Acids 9%
58. Comparative Genomic Hybridization 8%
59. Recurrence 8%
60. Palmitates 8%
61. Bortezomib 8%
62. Aplastic Anaemia 8%
63. Retrospective Studies 8%
64. Hematology 8%
65. Medical Oncology 8%
66. Apoptosis 8%
67. Remission Induction 8%
68. Multicenter Studies 8%
69. Survival Rate 8%
70. Exons 8%
71. Follicular Lymphoma 8%
72. Carboplatin 8%
73. Red cell phospholipid defect with hemolysis 8%
74. T-Lymphocytes 8%
75. Stem Cell Transplantation 7%
76. Interferons 7%
77. Proteins 7%
78. Phenotype 7%
79. Secondary Prevention 7%
80. Anaplastic Lymphoma Kinase 7%
81. Protein-Tyrosine Kinases 7%
82. VAP-cyclo protocol 7%
83. Immunotherapy 7%
84. Infections 7%
85. methyl caffeate 7%
86. Precursor Cell Lymphoblastic Leukemia-Lymphoma 7%
87. Cytarabine 7%
88. Tumor Burden 7%
89. Stomach Neoplasms 7%
90. Phosphatidylinositol 3-Kinases 7%
91. Allogeneic Cells 7%
92. N-nitrosobutylurea 7%
93. Viruses 7%
94. Fever 7%
95. Colorectal Neoplasms 6%
96. Osteoblasts 6%
97. Multiphoton Fluorescence Microscopy 6%
98. Reed-Sternberg Cells 6%
99. dendron 6%
100. Transplantation 6%